Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.4B | 6.0B | 3.0B | 2.9B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 382M | 332M | 330M | 461M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 73M | 96M | 99M | 95M |
| Other income expense | — | 252M | 217M | 200M |
| Pretax income | -369M | 925M | -45M | -29M |
| Tax provision | -87M | 349M | -110M | -298M |
| Net income | -282M | 576M | 65M | 269M |
| Basic EPS | -1.3 | 2.3 | 0.2 | 1.4 |
| Diluted EPS | -1.3 | 2.3 | 0.2 | 1.4 |
| Basic average shares | 173.8M | 173.8M | 92.2M | 123.3M |
| Diluted average shares | 173.8M | 173.8M | 92.2M | 123.3M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | 576M | 65M | — |
| Minority interests | -44M | -13M | -13M | -5M |
| Preferred stock dividends | — | — | — | — |